Logo

Spotfire, Iconix Partner in Tool Development

Aug 05, 2002

SAN FRANCISCO, Aug. 5 - Spotfire and Iconix Pharmaceuticals have partnered in a three-year collaboration to develop chemogenomics and toxicogenomics data analysis tools, the companies said today.

 

The collaboration will integrate Spotfire's visualization software with Iconix's content and data mining tools, said an Iconix spokesperson.

 

Spotfire's DecisionSite for Functional Genomics tools will be integrated with Iconix's DrugMatrix drug profiling and prediction system, which is being developed with MDS Pharma Services and offered by subscription by Incyte Genomics.

 

Financial details of the agreement were not disclosed.

 

Click here for more information.

Breaking News
The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.